From these reports, we suggest that inhibition of NRF2 in the advanced PCa, will increase zinc levels in the cancer cells and export citrate from the mitochondria, which will reduce TCA mediated metabolism and fatty acid synthesis. The gene discussed is NFE2L2; the disease is cancer.